Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | RECQL | P46063 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.53 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.53 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.53 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | FAAH | O00519 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | CNR1 | P21554 | 2/20 | 0.52 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 3/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8814970 | 1.00 | KDM4E (0.73) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL16800410 | 1.00 | KDM4E (0.73) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL469664 | 0.97 | KDM4E (0.73) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL8439129 | 0.97 | KDM4E (0.73) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL16800411 | 0.96 | KDM4E (0.71) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL17369041 | 0.96 | KDM4E (0.71) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL17369039 | 0.94 | KDM4E (0.75) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL7710665 | 0.94 | KDM4E (0.75) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL454163 | 0.94 | KDM4E (0.75) | KDM4EMEN1RECQLKMT2APOLM | |
| SCHEMBL16800397 | 0.91 | KDM4E (0.67) | KDM4EMEN1RECQLKMT2APOLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150374839-A1 | NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES | KEAN UNIVERSITY (US) | 2015-12-31 | — | — | US | disclosed |
| US-20150374839-A1 | NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES | KEAN UNIVERSITY (US) | 2015-12-31 | — | — | US | disclosed |
| US-9056139-B2 | Fatty acid-salicylate conjugates with enhanced therapeutic properties | KEAN UNIVERSITY (US) | 2015-06-16 | — | — | US | disclosed |
| US-9056139-B2 | Fatty acid-salicylate conjugates with enhanced therapeutic properties | KEAN UNIVERSITY (US) | 2015-06-16 | — | — | US | disclosed |
| WO-1997020212-A1 | TREATMENT OF INFLAMMATION BY INHIBITION OF LIPID BODY FORMATION | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 1997-06-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150374839-A1 | NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES | FASN, ELOVL1, ELOVL3 | KDM4E 2152/4885MEN1 4457/4885RECQL 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.